218 related articles for article (PubMed ID: 3235967)
1. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
Tung CC; Chang TC; Su CT; Chen FW; Chang CC
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
[No Abstract] [Full Text] [Related]
2. [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma].
Aritake S; Kusakabe K; Kanaya S; Kanaya K; Nakano K; Ota T; Maki M; Shigeta A
Kaku Igaku; 1993 Jan; 30(1):51-60. PubMed ID: 8455341
[TBL] [Abstract][Full Text] [Related]
3. Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I.
Zhu RS; Yu YL; Lu HK; Luo QY; Chen LB
Chin Med J (Engl); 2005 Mar; 118(5):425-8. PubMed ID: 15780216
[No Abstract] [Full Text] [Related]
4. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
[No Abstract] [Full Text] [Related]
5. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
[TBL] [Abstract][Full Text] [Related]
6. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
[TBL] [Abstract][Full Text] [Related]
7. [Dynamics of the x-ray picture of bone metastases of thyroid cancer as affected by radiotherapy].
Kiseleva ES; Zvekotkina LS; Babushkin VV
Med Radiol (Mosk); 1989 Mar; 34(3):6-10. PubMed ID: 2927278
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary metastases from differentiated thyroid carcinoma detected only by radionuclide imaging.
Casara D; Zorat PL; Busnardo B; Girelli ME
Br J Radiol; 1981 Apr; 54(640):362-3. PubMed ID: 7225731
[No Abstract] [Full Text] [Related]
9. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
[No Abstract] [Full Text] [Related]
10. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
11. An aggressive radio-resistant papillary thyroid cancer.
Mehta RS; Negin B; Popii V; Langer C
Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
[No Abstract] [Full Text] [Related]
12. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
[TBL] [Abstract][Full Text] [Related]
13. Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.
Koral KF; Adler RS; Carey JE; Beierwaltes WH
J Nucl Med; 1986 Jul; 27(7):1207-11. PubMed ID: 3723194
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.
Brown AP; Greening WP; McCready VR; Shaw HJ; Harmer CL
Br J Radiol; 1984 Apr; 57(676):323-7. PubMed ID: 6704664
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Takahashi K; Nakano S; Satoh K; Ohkawa M; Tanabe M
Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
[TBL] [Abstract][Full Text] [Related]
16. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
Yazici B; Ertan Y; Oral A; Akgün A
Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
[TBL] [Abstract][Full Text] [Related]
17. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
18. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
19. The treatment of metastatic thyroid disease.
Lee KY; Loré JM
Otolaryngol Clin North Am; 1990 Jun; 23(3):475-93. PubMed ID: 1973282
[TBL] [Abstract][Full Text] [Related]
20. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
[Next] [New Search]